2023 - Research.com Microbiology in Japan Leader Award
2022 - Research.com Microbiology in Japan Leader Award
Masashi Mizokami mainly investigates Virology, Genotype, Hepatitis B virus, Virus and Hepatitis C virus. His Virology study frequently links to adjacent areas such as Hepatocellular carcinoma. His research in Genotype intersects with topics in Liver disease and Immunology.
His biological study spans a wide range of topics, including Hepatitis B, Serotype and Distribution. As a member of one scientific family, Masashi Mizokami mostly works in the field of Virus, focusing on Hepatitis and, on occasion, Pathology. His work focuses on many connections between Hepatitis C virus and other disciplines, such as Replicon, that overlap with his field of interest in RNA.
Masashi Mizokami mainly focuses on Virology, Hepatitis B virus, Genotype, Hepatitis C virus and Internal medicine. The study incorporates disciplines such as Hepatocellular carcinoma and Immunology in addition to Virology. His Hepatitis B virus research is multidisciplinary, incorporating elements of Hepatitis B and Antigen.
His Genotype research incorporates elements of Liver disease and Polymerase chain reaction. His work deals with themes such as Interferon, Antibody and Hepatitis, which intersect with Hepatitis C virus. His research in Internal medicine focuses on subjects like Gastroenterology, which are connected to Chronic hepatitis.
His scientific interests lie mostly in Internal medicine, Hepatitis B virus, Virology, Gastroenterology and Genotype. He has included themes like Ribavirin and Hepatitis C virus in his Internal medicine study. Masashi Mizokami combines subjects such as Hepatitis B, Antigen and Hepatitis with his study of Hepatitis B virus.
Within one scientific family, he focuses on topics pertaining to Nucleoside under Virology, and may sometimes address concerns connected to Pharmacology. His Gastroenterology research integrates issues from Inflammation, Urine, Hepatitis C and Incidence. His Genotype research is within the category of Genetics.
His primary areas of study are Internal medicine, Hepatitis B virus, Gastroenterology, Virology and Hepatitis B. His studies in Hepatitis B virus integrate themes in fields like Signal transduction, Signal transducing adaptor protein, Stimulator of interferon genes and Colorectal surgery, Abdominal surgery. A large part of his Virology studies is devoted to Viral replication.
The concepts of his Hepatitis B study are interwoven with issues in Chemokine, Immune system and HBsAg. His Hepatitis C study combines topics from a wide range of disciplines, such as Clinical trial, Kidney disease, Sofosbuvir, Genotype and Ledipasvir. His Cirrhosis study incorporates themes from Liver biopsy, Cohort and Hepatitis C virus.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Production of infectious hepatitis C virus in tissue culture from a cloned viral genome
Takaji Wakita;Thomas Pietschmann;Takanobu Kato;Takanobu Kato;Tomoko Date.
Nature Medicine (2005)
Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C.
Yasuhito Tanaka;Nao Nishida;Masaya Sugiyama;Masayuki Kurosaki.
Nature Genetics (2009)
Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes.
Peter Simmonds;Jens Bukh;Christophe Combet;Gilbert Deléage.
A proposed system for the nomenclature of hepatitis C viral genotypes
P Simmonds;A Alberti;H J Alter;F Bonino.
Significance of serum hepatitis C virus RNA levels in chronic hepatitis C
J.Y.N Lau;G.L Davis;J Kniffen;K.-P Qian.
The Lancet (1993)
Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon
Takanobu Kato;Tomoko Date;Michiko Miyamoto;Akihiro Furusaka.
Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management.
Anna S. Lok;Fabien Zoulim;Stephen Locarnini;Angeline Bartholomeusz.
New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a.
O Ohno;M Mizokami;R R Wu;M G Saleh.
Journal of Clinical Microbiology (1997)
Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B
Man-Fung Yuen;Yasuhito Tanaka;Daniel Yee-Tak Fong;James Fung.
Journal of Hepatology (2008)
Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization
B Robertson;G Myers;C Howard;T Brettin.
Archives of Virology (1998)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: